Bruderman Asset Management’s Novo Nordisk NVO Stock Holding History

Bruderman Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,250	Closed	-$33K	–	412
2019 Q1	$33K	Hold	1,250	–	–	0.01%	317
2018 Q4	$29K	Buy	+1,250	New	+$27.8K	0.01%	300
2016 Q3	–	Sell	-26,334	Closed	-$708K	–	395
2016 Q2	$708K	Sell	26,334 -11,172	-30%	-$306K	0.22%	76
2016 Q1	$1.02M	Sell	37,506 -28,290	-43%	-$758K	0.35%	58
2015 Q4	$1.91M	Sell	65,796 -2,014	-3%	-$55.7K	0.72%	37
2015 Q3	$1.84M	Buy	67,810 +5,442	+9%	+$154K	0.72%	36
2015 Q2	$1.71M	Buy	62,368 +3,568	+6%	+$100K	0.66%	39
2015 Q1	$1.57M	Buy	+58,800	New	+$1.35M	0.61%	42

Other funds holding NVO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Bruderman Asset Management's NVO Position: Q2 2019 in Review

Bruderman Asset Management sold out of Novo Nordisk (NVO) in Q2 2019, closing a stake of 1,250 shares — an estimated $33K sold.

Bruderman Asset Management first reported a position in NVO in Q1 2015 and held it in 8 quarters. The position peaked at $1.91M in Q4 2015. 559 funds tracked by Wall St. Rank hold NVO as of Q2 2019.

Bruderman Asset Management reported no remaining Novo Nordisk position as of Q2 2019 after selling out during the quarter.
Bruderman Asset Management sold 1,250 Novo Nordisk shares in Q2 2019, an estimated $33K.
Bruderman Asset Management first reported a position in Novo Nordisk in Q1 2015 and held it in 8 quarters.
Bruderman Asset Management's Novo Nordisk position peaked at $1.91M in Q4 2015.
559 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2019.

Based on Bruderman Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.